(ReclaimingAmerica.net) – Conservative Americans’ fight against the unfettered access to abortion desired by the radical left is about to enter a critical new phase as the US Supreme Court has now scheduled the first hearing in a lawsuit over the availability of mifepristone, the so-called chemical abortion pill.
The mifepristone lawsuit will mark the court’s first revisit to the topic of abortion rights since the pivotal decision to revoke Roe v. Wade made in Dobbs v. Jackon Women’s Health Organization in June 2022.
On Monday, the court declared its plan to conduct oral hearings in the abortion pill lawsuit starting on March 26, 2024, Newsmax reports.
The case has been initiated by Alliance Defending Freedom, a conservative organization, which is challenging the Food and Drug Administration’s (FDA) amendments to the mifepristone regulations after 2016.
Previously, in August, a three-judge panel from the 5th Circuit Court of Appeals concluded that the drug should continue to be accessible for sale.
However, they stipulated that the FDA’s dosage and prescription instructions should revert to their pre-2016 status.
The Supreme Court decided to review this case back in December but had not specified a date for the oral arguments.
“Every court so far has agreed that the FDA acted unlawfully in removing common-sense safeguards for women and authorizing dangerous mail-order abortions,” Erin Hawley, senior counsel for Alliance Defending Freedom, told pro-left publication Politico.
“We urge the Supreme Court to do the same. The FDA has harmed the health of women and undermined the rule of law by illegally removing every meaningful safeguard from the chemical abortion drug regimen,” added the lawyer, who is married to US Senator Josh Hawley (R-MO).
In contrast, Evan Masingill, the chief executive of GenBioPro, a company producing a generic form of mifepristone, condemned the lawsuit.
“As we noted in our friend of the court brief earlier this year, disrupting the market for mifepristone would cause substantial, irreparable harm, and we call on the Supreme Court to reverse the Fifth Circuit’s ruling,” Masingill said in a statement.
“We remain concerned about extremists and special interests using the courts in an attempt to undermine science and access to evidence-based medication, as well as attempts to undermine the FDA’s regulatory authority,” the abortion drug producer argued.
